CN Patent

CN103958512A — 3,5-双取代炔基苯化合物及其盐

Assigned to Taiho Pharmaceutical Co Ltd · Expires 2014-07-30 · 12y expired

What this patent protects

本发明提供由通式(I)表示的化合物或其盐， (其中，R 1 、X 1 、X 2 、Y和Z如说明书中所定义的)。

USPTO Abstract

本发明提供由通式(I)表示的化合物或其盐， (其中，R 1 、X 1 、X 2 、Y和Z如说明书中所定义的)。

Drugs covered by this patent

Patent Metadata

Patent number
CN103958512A
Jurisdiction
CN
Classification
—
Expires
2014-07-30
Drug substance claim
No
Drug product claim
No
Assignee
Taiho Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.